432 related articles for article (PubMed ID: 33661103)
1. First Case of Symmetric Drug-Related Intertriginous and Flexural Exanthema Induced by Meropenem.
Blanco Garcia-Granero D; Barranco R; García-Moguel I; Velasco V; Diéguez Pastor MC
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):516-517. PubMed ID: 33661103
[No Abstract] [Full Text] [Related]
2. Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema.
Tsai YW; Chung WH; Wang CW; Cheng CY
Contact Dermatitis; 2022 Jan; 86(1):64-66. PubMed ID: 34553784
[No Abstract] [Full Text] [Related]
3. Itraconazole-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): a rare occurrence.
Kalita BJ; Das S; Dutta B
Int J Dermatol; 2020 Nov; 59(11):e419-e421. PubMed ID: 32767394
[No Abstract] [Full Text] [Related]
4. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
[No Abstract] [Full Text] [Related]
5. Zoledronic acid-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Kandala H; Gonzalez-Mosquera LF; Barua P; Podrumar A
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34518192
[No Abstract] [Full Text] [Related]
6. Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccine.
Orenay OM; Balta I; Yigit D; Eksioglu M
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e634-e635. PubMed ID: 34138472
[No Abstract] [Full Text] [Related]
7. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine.
Hong JK; Shin SH; Yoo KH; Li K; Seo SJ
Contact Dermatitis; 2022 Jul; 87(1):91-93. PubMed ID: 35243643
[No Abstract] [Full Text] [Related]
8. Symmetric Drug-Related Intertriginous and Flexural Exanthema.
Mansilla Polo M; Martín-Torregrosa D
N Engl J Med; 2024 Feb; 390(7):e17. PubMed ID: 38354144
[No Abstract] [Full Text] [Related]
9. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
[TBL] [Abstract][Full Text] [Related]
10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
Winnicki M; Shear NH
Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
[TBL] [Abstract][Full Text] [Related]
11. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
[TBL] [Abstract][Full Text] [Related]
12. Symmetric drug-related intertriginous and flexural exanthema due to super-bioavailable itraconazole.
Dhabal A; Das NK; Sil A
Indian J Pharmacol; 2023; 55(3):192-193. PubMed ID: 37555417
[No Abstract] [Full Text] [Related]
13. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
[TBL] [Abstract][Full Text] [Related]
14. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
[No Abstract] [Full Text] [Related]
15. Remifentanil-Induced Symmetric Drug-Related Intertriginous and Flexural Exanthema: A Diagnostic Challenge in an Intensive Care Patient.
Martins JF; Alen Coutinho I; Castro M; Carvalho J; Faria C; Sousa E; Martins P
J Investig Allergol Clin Immunol; 2022 Oct; 32(5):399-401. PubMed ID: 34779773
[No Abstract] [Full Text] [Related]
16. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
[TBL] [Abstract][Full Text] [Related]
17. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema.
Choi MJ; Oh SH; Cho SB
Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789
[No Abstract] [Full Text] [Related]
18. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
[No Abstract] [Full Text] [Related]
19. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
Moreira C; Cruz MJ; Cunha AP; Azevedo F
An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
[No Abstract] [Full Text] [Related]
20. Clozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported cases.
Rao A; Francis N; Morar N
Br J Dermatol; 2012 May; 166(5):1142-3. PubMed ID: 22121994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
